Literature DB >> 9792264

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children.

P Charron1, O Dubourg, M Desnos, J B Bouhour, R Isnard, A Hagege, L Carrier, G Bonne, F Tesson, P Richard, B Hainque, K Schwartz, M Komajda.   

Abstract

AIM: The aim of the study was to evaluate electrocardiography and echocardiography in the diagnosis of familial hypertrophic cardiomyopathy in children, using the genetic status as the criterion of reference. METHODS AND
RESULTS: We analysed 35 children (<18 years) from 13 families with identified mutations: 16 were genetically affected (11.2 +/- 3 years), 19 unaffected (13.1 +/- 2.8 years). Conventional major diagnostic criteria were: left ventricular wall thickness >95% confidence interval on the echocardiogram; abnormal Q waves, left ventricular hypertrophy (voltage >95th percentile), or marked ST-T changes on the electrocardiogram. Twenty-two minor electrocardiographic and echocardiographic criteria were also analysed. Using major criteria, the specificity of the electrocardiogram and echocardiogram was excellent (100% for both) but sensitivity was particularly low (38% and 50% respectively). However, when four relevant additional criteria (QRS axis, left atrium dimension, intraventricular septum/posterior wall ratio, E/A wave ratio) were taken into account, sensitivity increased to 88% and specificity remained high (95%).
CONCLUSIONS: (1) Familial hypertrophic cardiomyopathy was diagnosed in only approximately 50% of genetically affected children by conventional electrocardiographic and/or echocardiographic criteria. (2) Relevant additional diagnostic criteria were selected so that nearly all children considered as healthy carriers of a mutation (based on conventional criteria) could be identified with excellent specificity.

Entities:  

Mesh:

Year:  1998        PMID: 9792264     DOI: 10.1053/euhj.1998.1049

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Estimates of interventricular septum thickness are markedly affected by the method used.

Authors:  T Poutanen; T Tikanoja
Journal:  Pediatr Cardiol       Date:  2002-12-04       Impact factor: 1.655

Review 2.  Hypertrophic cardiomyopathy in childhood.

Authors:  Steven D Colan
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

Review 3.  Screening children with a family history of sudden cardiac death.

Authors:  Christopher Wren
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

Review 4.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Authors:  Lucie Carrier; Saskia Schlossarek; Monte S Willis; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

5.  Preventing sudden cardiac death in the young: Is electrocardiogram screening the most effective means?

Authors:  Robert Gow
Journal:  Paediatr Child Health       Date:  2009-03       Impact factor: 2.253

Review 6.  Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis.

Authors:  Angie Mae Rodday; John K Triedman; Mark E Alexander; Joshua T Cohen; Stanley Ip; Jane W Newburger; Susan K Parsons; Thomas A Trikalinos; John B Wong; Laurel K Leslie
Journal:  Pediatrics       Date:  2012-03-05       Impact factor: 7.124

7.  Therapeutic options in hypertrophic cardiomyopathy: a pediatric perspective.

Authors:  Edward K Rhee; John J Nigro; Stephen G Pophal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

8.  Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy.

Authors:  María Isabel Rodríguez-García; Lorenzo Monserrat; Martín Ortiz; Xusto Fernández; Laura Cazón; Lucía Núñez; Roberto Barriales-Villa; Emilia Maneiro; Elena Veira; Alfonso Castro-Beiras; Manuel Hermida-Prieto
Journal:  BMC Med Genet       Date:  2010-04-30       Impact factor: 2.103

9.  FHL2 expression and variants in hypertrophic cardiomyopathy.

Authors:  Felix W Friedrich; Silke Reischmann; Aileen Schwalm; Andreas Unger; Deepak Ramanujam; Julia Münch; Oliver J Müller; Christian Hengstenberg; Enrique Galve; Philippe Charron; Wolfgang A Linke; Stefan Engelhardt; Monica Patten; Pascale Richard; Jolanda van der Velden; Thomas Eschenhagen; Richard Isnard; Lucie Carrier
Journal:  Basic Res Cardiol       Date:  2014-10-31       Impact factor: 17.165

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.